Novel and founder pathogenic variants in x-linked alport syndrome families in greece

HIGHLIGHTS

• who: Despina Hadjipanagi and collaborators from the Syndrome Families in Greece biobankcy Center of Excellence in Biobanking and Biomedical Research, University of have published the research: Novel and Founder Pathogenic Variants in X-Linked Alport Syndrome Families in Greece, in the Journal: (JOURNAL)
• future: The prospects of avoiding lengthy diagnostic investigations and erroneous medications and the advantage of delaying kidney failure with very early administration of renin-angiotensin-aldosterone system (RAAS) blockade highlights the importance of timely documentation of AS by genetic diagnosis.

SUMMARY

Alport Syndrome (AS) is a genetically heterogeneous . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.